The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intracellular targeting of the oncogenic MUC1-C protein with a GO-203 nanoparticle formulation overcomes MCL-1- and BFL-1-mediated resistance in human carcinoma cells.
 
Masayuki Hiraki
No Relationships to Disclose
 
Caining Jin
No Relationships to Disclose
 
Maroof Alam
No Relationships to Disclose
 
Takahiro Maeda
No Relationships to Disclose
 
Masaru Murata
No Relationships to Disclose
 
Masahiro Hiratsuka
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Surender Kharbanda
Employment - Genus Oncology
Leadership - Genus Oncology
Stock and Other Ownership Interests - Genus Oncology (I)
Patents, Royalties, Other Intellectual Property - Genus Oncology
Travel, Accommodations, Expenses - Genus Oncology
 
Masaki Mori
No Relationships to Disclose
 
Donald W. Kufe
Leadership - Genus Oncology
Stock and Other Ownership Interests - Genus Oncology
Consulting or Advisory Role - Synta
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute (Inst)